81 related articles for article (PubMed ID: 3332182)
21. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
22. Donor leukocyte infusions in myeloid malignancies: new strategies.
Porter DL; Antin JH
Best Pract Res Clin Haematol; 2006; 19(4):737-55. PubMed ID: 16997180
[TBL] [Abstract][Full Text] [Related]
23. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease.
Johnson BD; Drobyski WR; Truitt RL
Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480
[TBL] [Abstract][Full Text] [Related]
24. Effector cells of graft-versus-host disease, host resistance, and the graft-versus-leukemia effect: summary of a workshop on bone marrow transplantation.
Ringdén O; Deeg HJ; Beschorner W; Slavin S
Transplant Proc; 1987 Feb; 19(1 Pt 3):2758-61. PubMed ID: 3547953
[No Abstract] [Full Text] [Related]
25. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
Kögler G; Hernandez A; Heyll A; Wolf HH; Wernet P
Cancer Detect Prev; 1996; 20(6):601-9. PubMed ID: 8939346
[TBL] [Abstract][Full Text] [Related]
26. Adoptive immunotherapy using donor leukocytes following bone marrow transplantation for chronic myeloid leukemia: is T cell dose important in determining biological response?
Mackinnon S; Papadopoulos EB; Carabasi MH; Reich L; Collins NH; O'Reilly RJ
Bone Marrow Transplant; 1995 Apr; 15(4):591-4. PubMed ID: 7655386
[TBL] [Abstract][Full Text] [Related]
27. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
Yee GC; McGuire TR
Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
[TBL] [Abstract][Full Text] [Related]
28. Bone-marrow transplantation in chronic myelogenous leukemia.
Jackson SJ; Jarolim DR
N Engl J Med; 1982 Jun; 306(22):1364-5. PubMed ID: 7040972
[No Abstract] [Full Text] [Related]
29. Bone marrow transplantation in chronic myelogenous leukemia.
Champlin RE; Goldman JM; Gale RP
Semin Hematol; 1988 Jan; 25(1):74-80. PubMed ID: 3279516
[No Abstract] [Full Text] [Related]
30. Bone marrow transplantation for chronic myelogenous leukemia: some thoughts about future prospects.
Ahmed T; Arlin ZA
Leukemia; 1988 Mar; 2(3):181. PubMed ID: 3279274
[No Abstract] [Full Text] [Related]
31. Bone marrow transplantation for the treatment of chronic myelogenous leukemia.
Storb R
Am J Med Sci; 1988 Aug; 296(2):87-94. PubMed ID: 3135753
[No Abstract] [Full Text] [Related]
32. Reply to Z. Arlin "Bone marrow transplantation for chronic myelogenous leukemia: some thoughts about future prospects".
Appelbaum FR
Leukemia; 1988 Apr; 2(4):251-2. PubMed ID: 3283470
[No Abstract] [Full Text] [Related]
33. Immunotherapy of AML: future directions.
Lowdell MW; Koh MB
J Clin Pathol; 2000 Jan; 53(1):49-54. PubMed ID: 10767857
[TBL] [Abstract][Full Text] [Related]
34. [Chronic granulocytic leukemia and HLA].
Hou YH; Zhong WM; Shen T
Zhonghua Nei Ke Za Zhi; 1988 Jan; 27(1):33-5, 71. PubMed ID: 3289857
[No Abstract] [Full Text] [Related]
35. Bone-marrow transplantation for chronic myelogenous leukaemia.
Goldman JM; Bortin MM; Champlin RE; Herzig RH; McGlave PB; Messner HA; Rimm AA; Speck B; Weiner RS
Lancet; 1985 Dec; 2(8467):1295. PubMed ID: 2866350
[No Abstract] [Full Text] [Related]
36. Eruptive vascular tumors associated with chronic graft-versus-host disease.
Garnis S; Billick RC; Srolovitz H
J Am Acad Dermatol; 1984 May; 10(5 Pt 2):918-21. PubMed ID: 6373861
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow transplantation for chronic myelogenous leukaemia.
Sauter C
Lancet; 1986 Jan; 1(8474):213. PubMed ID: 2868236
[No Abstract] [Full Text] [Related]
38. [Immunological disturbances in juvenile chronic myelocytic leukemia].
Shlesinger M; Handzel ZT; Barak Y; Levin S; Vardy P
Harefuah; 1979 Sep; 97(5-6):113-4. PubMed ID: 317264
[No Abstract] [Full Text] [Related]
39. New approaches to the treatment of chronic myelogenous leukemia.
McCredie KB; Kantarjian H; Keating MJ; Hester JP; Freireich EJ
Haematol Blood Transfus; 1985; 29():51-2. PubMed ID: 3896975
[No Abstract] [Full Text] [Related]
40. Bone marrow transplantation from programmed donor: one year on.
Burgio GR; Nespoli L; Porta F
Lancet; 1988 Apr; 1(8591):945. PubMed ID: 2895872
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
